APHA

APHA Articles

Canada-based pot grower Organigram had the same up-in-smoke year as most of the country's other cannabis producers. The company may get back on track this year.
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Many investors are focused on getting the jump on the cannabis industry, but they aren’t alone. With this increased speculation, there is added risk that has to be considered.
The December 13 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Pot stocks were a little higher on Friday after the Ontario government announced that it will abandon the current lottery system for cannabis retail.
The November 29 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Here is a look at how some of the individual legalized cannabis stocks were assigned coverage by Cantor Fitzgerald.
Aphria and these other stocks could prove to be exciting additions to portfolios looking for solid alpha potential.
Jefferies is out with a report cutting some price targets and ratings that comes as kind of a surprise, given the sharp sell-off in the cannabis industry over the past two months.
Cannabis stocks took a big hit on Thursday after Hexo gave an update on its fourth-quarter and full-year guidance.
With evolving societal and regulatory landscapes, the upside potential of cannabis as a new investment strategy has emerged. Investors can use a number of ETFs to invest in the future of cannabis.
Canadian marijuana grower Aphria posted a big loss Monday including a noncash impairment charge. But the settlement of a hostile takeover deal is likely what sent the share's tumbling.
It seems that cannabis stocks such as Canopy Growth and Tilray have become more normalized in the United States and legislation is on the way.